Lead sponsor
Seoul National University Hospital
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
712
Total enrollment
24
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Not applicable
3
Trials by status
Completed
4
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Brain Changes by Rivastigmine According to Butyrylcholinesterase AllelesAlzheimer's diseaseN/AUnknown70